...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Keystone Talk, Tues 3/19
Reply New Message
Back To Forum List View
Icon president Upcoming Zenith Events
4
BearDownAZ
Feb 18, 2019 01:01PM
Icon president Re: Upcoming Zenith Events
2
BearDownAZ
Feb 27, 2019 10:50PM
Icon president Zenith Keystone Talk, Tues 3/19
3
BearDownAZ
Mar 15, 2019 01:51PM
Re: Zenith Keystone Talk, Tues 3/19
3
Polar one
Mar 16, 2019 09:45AM
Re: Zenith Keystone Talk, Tues 3/19
4
Albertaclipper
Mar 17, 2019 07:20PM

The poster entitled "The BET Inhibitor ZEN-3694 Blocks Multiple Tumor Immune Suppressive Factors and has the Potential to Increase the Efficacy of Anti-PD1 Treatment" is available on the Zenith website or can be accessed here.

3 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply